Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 853 of 6351
-
Moderna launches first human test of mRNA vaccine against Epstein-Barr virus
Vaccine OngoingThe purpose of this study is to evaluate the safety and reactogenicity of mRNA-1195 in healthy participants.
Phase 1 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Aug 13, 2026 00:00 UTC
-
New pill could ease stiff back pain for thousands
Disease control OngoingThis study is comparing 200 milligrams (mg) of filgotinib a day with a placebo to see if filgotinib helps to treat Axial Spondyloarthritis (axSpA) and is safe to use. The study will also be comparing 200 mg with 100 mg filgotinib a day to see if the lower dose also helps to treat…
Phase 3 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Needle-Free hope: new shot delivery may ease myeloma treatment
Disease control OngoingThe main purpose of this study is to measure the efficacy (Myeloma response) of subcutaneous (SC) isatuximab treatment in combination with carfilzomib and dexamethasone in adult participants with RRMM having received 1 to 3 prior lines of therapy, and to characterize the PK of is…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for kids with severe asthma: drug aims to cut attacks
Disease control OngoingA study to evaluate the efficacy and safety of benralizumab administered subcutaneously in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations and uncontrolled asthma receiving high-dose inhaled corticost…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Belly fat graft could outsmart brain Cancer's defenses
Disease control Recruiting nowThis single center, single arm, open-label, phase I study will assess the safety of laparoscopically harvested autologous omentum, implanted into the resection cavity of recurrent glioblastoma multiforme (GBM) patients.
Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Magnesium shield: could a simple mineral prevent Chemo-Induced kidney failure?
Prevention Recruiting nowIn this research study, investigators will test whether prophylactic high-dose IV Mg administration attenuates the risk of AKI in patients with malignant mesothelioma receiving intraoperative chemotherapy (HIOC) with cisplatin compared to placebo .
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Could a sweetener stop deadly infections in transplant kids?
Disease control OngoingBloodstream infections (BSI) caused by bacteria translocating across injured oral mucosa are a significant cause of morbidity and mortality in patients undergoing stem cell transplantation (SCT). Unfortunately, there are currently no known strategies to prevent these BSI in this …
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a simple gum reshape baby brain health? a new study investigates
Knowledge-focused Recruiting nowThe goals of this study are to: evaluate and validate the low-cost, transportable, easily-administered Malawi Developmental Assessment Tool (MDAT) for neurodevelopmental assessment of children aged 4-8 years old in Malawi, as compared to the gold-standard yet more cumbersome and …
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
New hope for FSHD: experimental drug AOC 1020 completes early testing
Disease control CompletedA Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
Phase 1/2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New daily pill could rival insulin for diabetes and heart risk
Disease control CompletedThe main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes and obesity or overweight at increased cardiovascular risk. The study will last approximately 2 years may include up to 27 visits…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Experimental vaccine trains immune system to fight Hard-to-Treat cancers
Disease control OngoingThis is a pilot clinical trial for subjects with local advanced/metastatic solid tumors to determine the safety, efficacy and immune response of autologous EphA2-targeting CAR-DC vaccine loaded with KRAS mutant peptide (KRAS-EphA-2-CAR-DC) in combination with ICIs. It aims to: as…
Phase 1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a tiny implant curb alcohol cravings? new trial tests Long-Acting naltrexone
Disease control CompletedThis is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial. The study plans to enroll 210 adult patients with alcohol use disorder. After signing the informed consent form and undergoing screening based on inclusion/exclusion criteria, eligible pa…
Phase 2 • Sponsor: Shenzhen Sciencare Medical Industries Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo shot helps east asians shed pounds in major trial
Disease control CompletedThis study will look at how well the new medicine CagriSema helps people with excess body weight lose weight compared to another medicine, semaglutide. The participants will receive one injection once a week. The study medicine will be injected with a thin needle, typically in th…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Custom-Made immune cells take on incurable tumors
Disease control OngoingThis is a phase I/Ib study of adoptively transferred T-cell receptor gene-engineered T cells (TCR-T) targeting tumor-specific antigens, with in vivo CD40 activation and PD-1 blockade, for patients with incurable cancers. The study design is a safety lead-in TCR-T with CD40/PD-1 (…
Phase 1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a 2-Visit rabies vaccine schedule offer the same protection as 3?
Prevention CompletedThe goal of this clinical trial is to compare WHO recommended PrEP Vaccination Schedule, 2 doses 0.2ml 2 sites (0.1ml each site) on day 0 and day 7 and Government of India currently recommended PrEP Schedule, 0.1ml 3 doses on day 0, day 7 and day 28 in Healthy subjects above 18ye…
Phase 3 • Sponsor: Kempegowda Institute of Medical Sciences, Bangalore • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Can learning Self-Compassion break the chains of mental health stigma?
Symptom relief Recruiting nowPeople with mental disorders face frequent stigmatizing attitudes and behaviors from others . In response to this, they tend to isolate themselves, with the risk of impeding care and the process of recovery and integration into society . Stigmatization can also be assimilated by …
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Spinal zap: could a device restore arm movement after stroke?
Disease control Recruiting nowThis study aims to verify whether epidural electrical stimulation (EES) of the cervical spinal cord can activate muscles of the upper limbs in people with hemiplegia following a stroke.
Sponsor: Buddhist Tzu Chi General Hospital • Aim: Disease control
Last updated Jun 26, 2026 19:03 UTC
-
A simple mail delivery could boost colorectal cancer screening rates
Prevention CompletedThis is a randomized controlled trial comparing the effect on participation rates to colorectal cancer screening between an intervention arm (invitation letter to the screening program including a FIT test with or without prior notification) and a control arm with the standard of…
Sponsor: International Agency for Research on Cancer • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Adaptive radiation aims to outsmart aggressive brain tumors
Disease control OngoingThe goal of this study is to test whether an adaptive radiation therapy (RT), two-phase approach in participants with glioblastoma impacts local control compared to standard non-adaptive RT approach. The main questions of the study are to see how this adaptive, two-phase RT appro…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could fewer dialysis sessions preserve kidney function and boost quality of life?
Disease control Recruiting nowIn this pragmatic clinical trial, which will dovetail with Veterans' routine outpatient dialysis clinic visits in six VA medical centers, the investigators will study 252 Veterans with kidney disease who need to start dialysis treatment. If a Veteran is eligible for the study by …
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC